Research Topics
Species | J GrebelySummaryAffiliation: University of New South Wales Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residentsJ Grebely
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, NSW, Australia
J Viral Hepat 16:352-8. 2009..There are extremely low rates of HCV treatment initiation and very limited effectiveness, despite a high prevalence of HCV infection in this large community-based cohort of inner city residents with access to universal healthcare...
Treatment of acute HCV infectionJason Grebely
Viral Hepatitis Clinical Research Program, National Center in HIV Epidemiology and Clinical Research, University of New South Wales, Corner Boundary and West Streets, Darlinghurst, Sydney, NSW 2010, Australia
Nat Rev Gastroenterol Hepatol 8:265-74. 2011..This Review highlights current knowledge of the epidemiology, diagnosis, natural history and treatment of acute HCV infection, including proposed recommendations for the assessment and treatment of this infection...
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug usersJason Grebely
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
J Hepatol 55:76-85. 2011..We assessed 80/80 adherence (≥80% of PEG-IFN doses, ≥80% treatment), on-treatment adherence, and treatment completion in a study of treatment of recent HCV infection (ATAHC)...
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, AustraliaJ Grebely
Viral Hepatitis Clinical Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
J Viral Hepat 18:e104-16. 2011..22, P < 0.001). These data identify modifiable patient-, provider- and systems-level barriers associated with HCV assessment and treatment in the community that could be addressed by targeted interventions...
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionJason Grebely
National Centre in HIV Epidemiology and Clinical Research NCHECR, University of New South Wales UNSW, Sydney, Australia
Hepatology 52:1216-24. 2010..Early therapeutic intervention could be recommended for individuals with unfavorable IL28B genotypes...
Reinfection with hepatitis C virus following sustained virological response in injection drug usersJason Grebely
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia
J Gastroenterol Hepatol 25:1281-4. 2010..However, there are little data in this regard. We evaluated HCV re-infection following sustained virologic response (SVR) among HCV-infected IDUs having received HCV treatment in a multidisciplinary program...
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer supportJason Grebely
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, New South Wales, Australia
Eur J Gastroenterol Hepatol 22:270-7. 2010..We evaluated assessment and treatment for hepatitis C virus (HCV) among illicit drug users accepting referral to a weekly HCV peer-support group at a multidisciplinary community health centre...
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residentsJ Grebely
National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
J Viral Hepat 18:32-41. 2011..HCV-infected inner city residents >50 years of age were at significant risk of liver-related mortality. Continued surveillance of this population infected with HCV in the 1970s and 1980s is important...
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC StudyJ Grebely
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
Drug Alcohol Depend 107:244-9. 2010..Decisions about whether to initiate treatment for recently acquired HCV were mainly driven by clinical factors, rather than factors related to sociodemographics or injecting behaviors...
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis CG V Matthews
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
Clin Infect Dis 52:803-11. 2011..The extent to which these separate epidemics overlap is unknown...
